| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/13/2009 | EP2057996A2 Y4 selective receptor agonists for therapeutic intervention |
| 05/13/2009 | EP2057274A2 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 05/13/2009 | EP2057195A2 Pharmaceutical composition for suppression of apoptosis and method for delivering the same |
| 05/13/2009 | EP2057189A1 Acylated exendin-4 compounds |
| 05/13/2009 | EP2057188A2 Dpp-iv resistant gip hybrid polypeptides with selectable properties |
| 05/13/2009 | EP2057185A1 Polymyxin derivatives and uses thereof |
| 05/13/2009 | EP2057184A2 Cyclic angiotensin analogs |
| 05/13/2009 | EP2056868A1 Inhibition of angiogenesis, tumorigenesis and cathepsin activity using insulin-like growth factor binding protein |
| 05/13/2009 | EP2056867A2 Cystatin from nematodes in the treatment of autoimmune or allergic diseases |
| 05/13/2009 | EP2056866A2 Use of a botulinum toxin for treating a urethral stricture |
| 05/13/2009 | EP2056865A2 Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health |
| 05/13/2009 | EP2056864A2 Candidates against infection |
| 05/13/2009 | EP2056863A2 Treatment of ocular diseases |
| 05/13/2009 | EP2056862A2 Parathyroid hormone analogues and uses thereof |
| 05/13/2009 | EP2056861A2 Vaccine immunotherapy |
| 05/13/2009 | EP2056860A2 Il-17a/f heterodimeric polypeptides and therapeutic uses thereof |
| 05/13/2009 | EP2056859A2 Promiscuous pap cd4 t cell epitopes |
| 05/13/2009 | EP2056857A2 Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation |
| 05/13/2009 | EP2056856A2 Use of tenecteplase for treating acute ischemic stroke |
| 05/13/2009 | EP2056855A1 Method of treatment of photodermatoses |
| 05/13/2009 | EP2056854A1 Method for reducing incidence or rate of development of skin cancers and related conditions |
| 05/13/2009 | EP2056853A1 Combination therapy |
| 05/13/2009 | EP2056852A2 Bmp-7 variant compositions, methods and uses |
| 05/13/2009 | EP2056851A1 Organ preservation and/or perfusion |
| 05/13/2009 | EP2056850A2 Therapeutic methods for neuropathic pain |
| 05/13/2009 | EP2056849A2 Methods and compositions for treating ige-mediated diseases |
| 05/13/2009 | EP2056846A2 Salivary substitute |
| 05/13/2009 | EP2056838A2 Combination therapy for treatment of immune disorders |
| 05/13/2009 | EP2056803A2 Thiol-based agents for reducing toxicities associated with medical procedures employing radiographic contrast agents |
| 05/13/2009 | EP1848804A4 Anti-muci alpha beta antibodies |
| 05/13/2009 | EP1843749B1 Controlled release compositions for interferon based on pegt/pbt block copolymers |
| 05/13/2009 | EP1608745B1 FVII OR FVIIa VARIANTS |
| 05/13/2009 | EP1490490B1 Antisense iap nucleobase oligomers and uses thereof |
| 05/13/2009 | EP1485477B1 Novel type-1 cytokine receptor glm-r |
| 05/13/2009 | EP1466174B1 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 05/13/2009 | EP1320540B1 Peptidomimetic protease inhibitors |
| 05/13/2009 | EP1317536B1 Tnf receptor-like molecules and uses thereof |
| 05/13/2009 | EP1309692B1 Anti-il-12 antibodies, compositions, methods and uses |
| 05/13/2009 | EP1299104B1 Tamper-resistant oral opioid agonist formulations |
| 05/13/2009 | EP1294891B1 Transport peptides derived from erns protein |
| 05/13/2009 | EP1232252B1 Reversibly inactivated acidified plasmin |
| 05/13/2009 | EP1178818A4 A stable composition comprising epidermal growth factor as an active ingredient |
| 05/13/2009 | EP1165807B1 A protease, a gene therefor and the use thereof |
| 05/13/2009 | EP1115743B1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 05/13/2009 | EP0914325B1 Modulators of the function of fas receptors and other proteins |
| 05/13/2009 | CN201234980Y Vacuum blood sampling tube |
| 05/13/2009 | CN101432428A Recombinant human interferon-like proteins |
| 05/13/2009 | CN101432307A Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 05/13/2009 | CN101432302A Anti-a globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibod |
| 05/13/2009 | CN101432296A Pegylated mutated clostridium botulinum toxin |
| 05/13/2009 | CN101432295A Peptide |
| 05/13/2009 | CN101432294A Compounds analogous to growth hormone peptide secretagogues and preparations containing them |
| 05/13/2009 | CN101432020A Methods and materials for the inhibition of transplant rejection |
| 05/13/2009 | CN101432014A Cathepsin propeptide and uses thereof |
| 05/13/2009 | CN101432013A Use of antisecretory factors for treating intraocular hypertension |
| 05/13/2009 | CN101432012A Pharmaceutical combination for the treatment and or chemosensibilization of refractory tumors to anticancer drugs |
| 05/13/2009 | CN101432011A Methods for regulating neurotransmitter systems by inducing counteradaptations |
| 05/13/2009 | CN101432010A Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells |
| 05/13/2009 | CN101431980A Fermented product composition, cosmetic composition and method of producing the same |
| 05/13/2009 | CN101431960A Intraventricular enzyme delivery for lysosomal storage diseases |
| 05/13/2009 | CN101429525A Antineoplastic invasion transfer function of snake venom metalloprotease inhibitors BJ46a and uses thereof |
| 05/13/2009 | CN101429251A Antineoplastic amalgamation protein, preparation method and uses thereof |
| 05/13/2009 | CN101429239A Anti-atherosis epitope composition, preparation method and uses thereof |
| 05/13/2009 | CN101429235A New high-efficiency low-toxicity actinomycin type D antineoplastic compound |
| 05/13/2009 | CN101429232A Hcv protease inhibitors |
| 05/13/2009 | CN101429231A Antihypertensive active kyrine, preparation and uses thereof |
| 05/13/2009 | CN101428142A Process for producing recombinant human vascular endothelial inhibitor composition sustained-release microsphere |
| 05/13/2009 | CN101428141A Recombinant human vascular endothelial inhibitor sustained-release injection oil formulation and preparation thereof |
| 05/13/2009 | CN101428140A Sustained-release incretion particle for inducing maturation of Oplegnathus fasciatus gonad and preparation method thereof |
| 05/13/2009 | CN101428139A Method for extending spermiation period of verasper moseri |
| 05/13/2009 | CN101428138A Uses of Chilobrachys jingzhao toxin extract-jingzhao toxin-V in preparing pain easing medicament |
| 05/13/2009 | CN101428137A Composition for diminishing neutral fat in blood |
| 05/13/2009 | CN101428136A Uses of recombinant protein in preparing oral medication for preventing diabetes |
| 05/13/2009 | CN101428056A Health care formulation for improving osteoporosis of female in middle and old age and preparation method thereof |
| 05/13/2009 | CN101428039A Educated nk t cells and their uses in the treatment of immune-related disorders |
| 05/13/2009 | CN101428009A Insulin intranasal inhalation powder spray |
| 05/13/2009 | CN101427996A Novel anticancer sustained-release injection |
| 05/13/2009 | CN100486996C Antibodies to human MCP-1 |
| 05/13/2009 | CN100486995C Compositions and methods for WT1 specific immunotherapy |
| 05/13/2009 | CN100486992C Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiongenesis |
| 05/13/2009 | CN100486991C Screening and authentication of polypeptide binding specificly to tumour tranferring cell |
| 05/13/2009 | CN100486990C Glutathione calcium chelate and its preparing method, use and composition |
| 05/13/2009 | CN100486641C Compound bone peptide medicine composition oral preparation and preparation method therefor |
| 05/13/2009 | CN100486471C Magnetic beads activity factor cream massage bra |
| 05/13/2009 | CN100486444C Human colostrum-simulated biological milk powder |
| 05/13/2009 | CN100486426C Method for constructing allotetraploid of bluntsnout bream |
| 05/12/2009 | US7531676 Bipolar; cationic head linked to a hydrophobic backbone and a hydrophilic tail; capable of self assembly to form stable complexes in aqueous solutions; use for the delivery of bioactive substances such as nucleic acids to cells in vitro and especially in vivo |
| 05/12/2009 | US7531645 By ion exchange chromatography and involves changing the conductivity and/or pH of buffers in order to resolve the polypeptide of interest |
| 05/12/2009 | US7531644 In which IL-6R and IL-6 are directly linked without a linker; blood platelet proliferating agent, ex vivo amplifier for hematopoietic stem cells |
| 05/12/2009 | US7531636 A proinflammatory cytokine; monoclonal antibodies, or mixture of polyclonal antibodies; blocks signal transduction; hematopoietic cell proliferation |
| 05/12/2009 | US7531633 Immunotherapy against infection; harvesting antibodies directed against Staphylococcus from blood of immunized subject for use as immunotherapeutic agents |
| 05/12/2009 | US7531630 Interferon-alpha polypeptides and conjugates |
| 05/12/2009 | US7531629 Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| 05/12/2009 | US7531627 Protein ACA1 of Antrodia camphorata |
| 05/12/2009 | US7531625 Nucleotide sequences coding neuronal outgrowth and stability protein for use in treating ovarian, renal, neurological, cell proliferative and cardiovascular disorders |
| 05/12/2009 | US7531624 Nuclear targeting sequence |
| 05/12/2009 | US7531623 Such as of telavancin isolated via precipitation, filtration; storage stability |
| 05/12/2009 | US7531622 Synthesis and characterization of novel systems for guidance and vectorization of molecules of therapeutic interest towards target cells |
| 05/12/2009 | US7531621 Of the formula, [Cha7,11, des-Met8, Nle18, Tyr34]hPTH(1-34)NH2; disorders of the central nervous system, metabolism, pancreas, and hypothalmus; irregular blood pressure, male infertility; agonists or antagonists |
| 05/12/2009 | US7531538 α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |